NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Institute of Medicine (US) Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings; Curran J, Debas H, Arya M, et al., editors. Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities. Washington (DC): National Academies Press (US); 2005.
Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities.
Show detailsCommittee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings
Tuesday, January 27, 2004
Room 100, Keck Building
500 5th Street, NW
Washington, DC 2001
| 8:00-8:20 | Welcome, Introduction of Committee, and Statement of Charge |
| Dr. James Curran and Dr. Haile Debas | |
| Committee Cochairs |
The Opportunity
| 8:20-8:45 | The Challenge of HIV/AIDS in 2004 and the WHO 3 × 5 Program |
| Dr. Jim Kim | |
| Advisor to the Director-General | |
| World Health Organization | |
| Geneva, Switzerland | |
| 8:45-9:10 | The Global Funds' Lessons Learned Regarding ARV Drug Scale-up in Resource-Constrained Settings |
| Dr. Bernhard Schwartlander | |
| Director | |
| Strategic Information and Measurement | |
| Global Fund to Fight AIDS, TB, and Malaria | |
| Geneva, Switzerland | |
| 9:10-9:35 | The U.S. Emergency Plan for Antiretroviral Scale-up: The Latest Programmatic Developments |
| Dr. Joe O'Neil | |
| Deputy Coordinator | |
| Office of the Global AIDS Coordinator | |
| Department of State | |
| Washington, DC | |
| 9:35-9:55 | General Discussion |
| 9:55-10:15 | BREAK |
Antecedents
| 10:15-10:40 | Durability of ARV Therapy: U.S. Experience and Its Implications for Resource-Constrained Settings |
| Dr. Robert Redfield | |
| Cofounder and Director of Clinical Care and Research Division, Institute of Human Virology | |
| University of Maryland | |
| Baltimore, MD | |
| 10:40-11:05 | A U.S. Clinical Perspective on the Implications of ARV Resistance for Resource-Constrained Settings |
| Dr. Steven Deeks | |
| Associate Clinical Professor of Clinical Medicine | |
| University of California, San Francisco | |
| San Francisco, CA | |
| 11:05-11:30 | Lessons Learned from the Scale-up of ARV Treatment in Brazil |
| Dr. Mauro Schechter | |
| Professor of Infectious Diseases | |
| Universidade Federal do Rio de Janeiro, Brazil | |
| 11:30-11:55 | Lessons Learned from the Use of ARVs in Very Low-Resource Settings: The Haiti Experience |
| Dr. Daniel Fitzgerald | |
| Groupe Haitien d'Étude du Sarcome de Kaposi et des infections Opportunistes (GHESKIO) Port-au-Prince, Haiti, and | |
| Division of International Medicine and Infectious Diseases | |
| Cornell University Medical College | |
| New York, NY | |
| 11:55-12:20 | MSF Perspectives on ARV Administration: Experiences from 20 countries and 10,000 Patients |
| Ms. Rachel Cohen | |
| U.S. Director, Campaign for Access to Essential Medicines | |
| Médecins sans Frontières | |
| New York, NY | |
| 12:20-12:50 | General Discussion |
| 12:50-1:50 | LUNCH |
Clinical Principles for ARV Scale-up Programs
| 1:50-2:15 | The 2003 WHO Guidelines for ARV Use: Perspectives from a User |
| Dr. John Idoko | |
| Professor | |
| Jos University Teaching Hospital | |
| Jos, Nigeria | |
| 2:15-2:40 | MTCT-Plus Initiative: Perspectives from a Multicountry Comprehensive HIV Care and Treatment Program |
| Dr. Wafaa El-Sadr | |
| Professor | |
| Mailman School of Public Health | |
| Columbia University and Harlem Hospital | |
| New York, NY | |
| 2:40-3:05 | The Role of the Laboratory in Managing ARV Care in a Country with Highly Limited Resources |
| Dr. Brooks Jackson | |
| Baxley Professor and Director of Pathology | |
| Johns Hopkins University School of Medicine | |
| Baltimore, MD | |
| 3:05-3:30 | The Social and Behavioral Dimensions of Adherence: Implications for Patient Education |
| Dr. Carla Makhlouf Obermeyer | |
| Scientist | |
| Department of HIV/AIDS | |
| World Health Organization | |
| Geneva, Switzerland | |
| 3:30-3:50 | General Discussion |
| 3:50-4:10 | BREAK |
| 4:10-4:35 | Preventing Mother-to-Child Transmission: Issues of Therapy and Resistance |
| Dr. Lynne Mofenson | |
| Pediatric, Adolescent and Maternal AIDS Branch | |
| Center for Research for Mothers and Children | |
| National Institute of Child Health and Human Development | |
| National Institutes of Health | |
| Bethesda, MD | |
| 4:35-5:00 | Pediatric Considerations for ARV Programs in Resource-Constrained Settings |
| Dr. Mark Kline | |
| Chief, Retrovirology Clinic | |
| Professor of Pediatrics | |
| Director, Baylor International Pediatric AIDS Initiative | |
| Baylor College of Medicine/Texas Children's Hospital | |
| Houston, TX | |
| 5:00-5:25 | The Integration of Counseling, Prevention, and ARV Programs |
| Dr. Sam Dooley | |
| Division of HIV/AIDS Prevention | |
| Centers for Disease Control and Prevention | |
| Atlanta, GA | |
| 5:25-6:00 | Wrap-up Comments and Discussion |
Wednesday, January 28, 2004
Management Principles for Scale-up of ARV Programs
| 8:00-8:05 | Opening Comments |
| Dr. James Curran and Dr. Haile Debas | |
| Committee Cochairs | |
| 8:05-8:30 | Principles of Design and Scale-up for National Clinical Care Programs and Applications to the WHO 3 × 5 Targets |
| Dr. M. Rashad Massoud | |
| Vice President and Director | |
| Quality and Performance Institute | |
| University Research Co., LLC | |
| Bethesda, MD | |
| 8:30-8:55 | An Overview of Health Care Manpower, Health Care Infrastructure, and Economics in Select Resource-Poor Countries |
| Mr. Mead Over | |
| Lead Economist | |
| Development Research Group | |
| World Bank | |
| Washington, DC | |
| 8:55-9:20 | The Role of Community Mobilization in the Scale-up of ARV programs |
| Ms. Emi MacLean | |
| Médecins sans Frontières | |
| New York, NY | |
| 9:20-9:45 | Distribution of ARVs: Issues of Security, Logistics, and Quality |
| Ms. Yasmin Chandani | |
| HIV/AIDS Advisor for DELIVER | |
| John Snow, Inc. | |
| Arlington, VA | |
| 9:45-10:10 | Large Scale Training for ARV Providers: Observations from the United States |
| Dr. John McNeil | |
| Chief, Infectious Diseases | |
| Howard University | |
| PI, National Minority AIDS Education and Training Center | |
| Washington, DC | |
| 10:10-10:30 | General Discussion |
| 10:30-10:50 | BREAK |
| 10:50-11:15 | Perspectives on Purchasing First and Second Line ARVs |
| Ms. Lynn Margherio | |
| Executive Vice President | |
| The Clinton Foundation HIV/AIDS Initiative | |
| 11:15-11:40 | Delivering ARVs: The Economic Consequences of Resistance |
| Dr. Stefano Bertozzi | |
| Director | |
| Economics and Policy | |
| Center of Research on Health Systems | |
| National Institute of Public Health | |
| Cuernavaca, Mexico | |
| 11:40-12:00 | General Discussion |
| 12:00-1:00 | LUNCH |
The Path Forward
| 1:00-1:25 | Assessing Readiness for ARV Program Implementation |
| Dr. Eric Goosby | |
| Chief Executive Officer | |
| Pangea Global AIDS Foundation | |
| San Francisco, CA | |
| 1:25-1:50 | Specific Questions for Operations Research in the Scale-up of ARV Treatment Programs in Low-Resource Settings |
| Dr. Tom Quinn | |
| Professor of Medicine | |
| Johns Hopkins University School of Medicine | |
| Baltimore, MD | |
| 1:50-2:15 | The Role of Statistical Prediction Methods for Managing ARV Scale-up Programs |
| Dr. Victor De Gruttola | |
| Professor of Biostatistics | |
| Harvard School of Public Health | |
| Boston, MA | |
| 2:15-2:40 | Ethical Issues in the Scale-up of ARV Programs in Resource-Poor Settings |
| Ms. Angela Wasunna | |
| Lawyer/Bioethicist | |
| Associate for International Programs | |
| The Hastings Center | |
| Garrison, NY | |
| 2:40-3:05 | Discussion |
| 3:05-3:30 | BREAK |
| 3:30-3:55 | Information Management Considerations in Managing ARV Programs |
| Mr. Ronaldo Lima | |
| International AIDS Vaccine Initiative | |
| New York, New York | |
| 3:55-4:20 | ARV Resistance: Epidemiologic Implications and Public Health Surveillance |
| Dr. Diane Bennett | |
| World Health Organization | |
| Geneva, Switzerland | |
| 4:20-4:45 | Monitoring and Evaluation for ARV Programs in Resource-Poor Settings |
| Dr. Paul DeLay | |
| UNAIDS | |
| Geneva, Switzerland | |
| 4:45-5:10 | The South African Plan for ARV Scale-up |
| Dr. Tony Mbewu, | |
| Executive Director | |
| Medical Research Council of South Africa | |
| Capetown, South Africa | |
| 5:10-6:00 | Discussion and Wrap-up |
- Information Gathering Workshop Agenda - Scaling Up Treatment for the Global AIDS...Information Gathering Workshop Agenda - Scaling Up Treatment for the Global AIDS Pandemic
Your browsing activity is empty.
Activity recording is turned off.
See more...